Skip to content

Capsular Repair in FAI Impingement Surgery

The Efficacy of Capsular Repair in Arthroscopic Femoroacetabular

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02990234
Enrollment
23
Registered
2016-12-13
Start date
2014-03-31
Completion date
2017-10-31
Last updated
2017-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Injuries

Keywords

Capsular Repair, FAI, Hip

Brief summary

The Investigator's hypothesis is that capsular repair (after CAM or mixed Femoroacetabular Impingement (FAI) surgery) requiring moderate capsulotomy, would result in similar patient outcomes in the short, mid and long term, both clinically and radiographically, compared to those without capsular repair. The objective of this clinical trial is to evaluate the clinical efficacy with regards to pain, range of motion and return to work and activities of daily living. Secondary objective is to evaluate radiographic characteristics between both groups.

Interventions

PROCEDURECapsular Repair
PROCEDURENo Capsular Repair

Sponsors

University of Colorado, Denver
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
16 Years to 51 Years
Healthy volunteers
No

Inclusion criteria

1. Male or female patients aged between 16-51 years of age. 2. Healthy patients undergoing hip arthroscopy due to Cam or mixed FAI 3. No major osteoarthritic (OA) changes according to X-Ray and surgery observation (Tonnis 0-1) 4. No previous hip surgery 5. No other influential disabilities in lower limbs 6. No chronic use of NSAID, analgesics, steroids or chemotherapy drugs 7. Base line activity level (Tegner 3 and above)

Exclusion criteria

1. Patients with concomitant disease that may affect joints 2. Patients with major ligamentous laxity 3. Patients who have undergone only minor vertical capsulotomy (as in small pincer only lesions) 4. Patients with extreme range of motion needs (such as ballet dancers) 5. Patients suffering from connective tissue disease 6. Patients suffering from bilateral symptomatic FAI that are being operated on for their first hip 7. Patients with relative or proven dysplastic hip determined by center edge angle and/or extreme version abnormalities as measured on apical CT/MR cuts and pelvic XR 8. Patients who needed Ilio-Psoas release 9. Patients whose cartilage hip status was defined as advanced OA during surgery 10. Patients who following surgery would be instructed to avoid full weight bearing on the operated hip for more than 4 weeks 11. Concomitant use of PRP (platelet rich plasma) or hyaluronic acid during the surgical procedure 12. Patients with preoperative hip stiffness

Design outcomes

Primary

MeasureTime frame
Change in iHOT Version 12Baseline, 6weeks, 12weeks, 6months, 1Year, 2Years

Other

MeasureTime frameDescription
Change in Marx activity scoreBaseline, 6weeks, 12weeks, 6months, 1Year, 2Years
Change in Range of MotionBaseline, 14days, 6weeks, 12weeks, 6months, 1Year, 2Years
Change in X-rays6weeks, 6months, 1YearXR will be used for initial evaluation and for post op resection assessment and long-term OA changes. X-rays will be done post-operatively at 6 weeks, 6 months and 1 year time-frames. All these x-rays are normally performed as standard of care.
Change in MRI6weeks, 6monthsMRI will be conducted at 6 weeks and 6 months post op to evaluate capsular healing status (primary radiological outcome measure), intra articular adhesions, extra articular scarring, labrum/cartilage status and resection assessment. This MRI will be paid by department funds.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026